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Acquired immune responses against hapten-carrier systems have been used in mammals and 
teleosts in vivo as an effective means of identifying and characterizing T and B cell activity. Fish 
immunized by intraperitoneal (ip) injection of the hapten-carrier system FITC-KLH develop 
strong serum antibody responses to both the hapten (FITC) and carrier protein (KLH; Jones et 
al., 1999). In contrast, fish immunized with FITC-KLH by peranal (pa) intubation results in a 
failure to develop a detectable anti-KLH response in the serum, yet they still develop a 
significant anti-FITC response. To investigate the nature of the antibody secreting cell (ASC) 
response in the systemic (head kidney and spleen) and mucosal tissues (hindgut and gills) of 
trout, ELISA-based serum and cellular assays were utilized to detect serum and tissue-specific 
antibody responses to FITC and KLH. Given the distinction in serum responsiveness to FITC- 
KLH through the ip and pa routes, an identification of where the B cell tissue-specific responses 
were occurring would identify if there is a restricted B cell population in the mucosal tissues of 
rainbow trout. In the primary response to immunization with FITC-KLH, systemically 
challenged fish presented ASC activity in systemic tissues, while mucosally challenged fish 
presented ASC activity in a mixture of both systemic and mucosal tissues. In the secondary 
response to FITC-KLH, in fish immunized via a combination of systemic and mucosal routes 
there was a utilization of both systemic and mucosal tissues in the response. It is possible that 
immunization with FITC-KLH through the mucosal or systemic routes may cause presentation 
of FITC-KLH in the systemic tissues, resulting in trafficking of ASC or antigen presenting cells 
(APC) between the mucosal and systemic tissues. To examine the relationships within and 
between the B cell populations of the lymphoid tissues, the rearranged Vh gene repertoire was 
examined in the tissues with ASC activity. Identification of preferential or restricted use of the 
different Vh genes may provide further insight into the restricted serum response to KLH in 
mucosally challenged fish, and whether restricted populations of B cells exist within the 
mucosal tissues. A qRT-PCR assay was developed and optimized using non-immunized trout to 
analyze the use of Vh gene families VH-I to Vh-XI in rearranged Ig genes in the lymphoid 
tissues of trout. All Vh gene families were amplified across the tissues tested. In the primary 
response to immunization with FITC-KLH, families with the highest fold changes in gene 
expression for both systemic and mucosal tissues were Vh-VI, Vh-VIII, Vh-IX, Vh-X and Vh-
xvi
XI. In the secondary response, families Vh-I, Vh-II, Vh-V, Vh-IX, Vh-X and Vh-XI had the 
highest fold changes in gene expression. Gaps in the repertoire were also apparent within the 
primary ASC response to FITC-KLH, and were mainly associated with families Vh-I, Vh-II, 
VH-III, VH-IV, VH-V and VH-VII. In the secondary ASC response study to FITC-KLH, systemic 
tissue contained few repertoire gaps, however in mucosal lymphoid tissues there was evidence 
of repertoire gaps for families VH-I, Vh-II, VH-III, Vh-IV, Vh-V, Vh-VI, Vh-VII and Vh-VIII. A 
similar pattern of expression for the Vh gene families could suggest B cells migrate to the 
different tissues from a common source, perhaps from the head kidney given its role as a 
primary lymphoid tissue. Alternatively, families present in high abundance may have a larger 
number of germline members, or are highly expressed due to an unknown antigenic challenge. 
This study is one of the first to identify the extent of the usage of the Vh gene families in these 
tissues.
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